Reply: Searching for Optimal Prognostic Marker of Heart Failure Progression in the Era of ARNI.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.05.006
Abstract: In our recent paper [(1)][1], we demonstrated that both B-type natriuretic peptide (BNP) and N-terminal pro-BNP at baseline and during treatment with angiotensin receptor-neprilysin inhibitor (ARNI) were found to be independently and comparably associated with… read more here.
Keywords: arni; searching optimal; reply searching; prognostic marker ... See more keywords
P5436Angiotensin receptor-neprilysin inhibitor preserved cardiac function via improving angiogenetic ability in mice model of atherosclerosis
Sign Up to like & getrecommendations! Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz746.0392
Abstract: Angiotensin receptor-neprilysin inhibitor (ARNI) increases natriuretic peptide and improves heart failure. We previously reported that ARNI has the effects of suppression of myocardial hypertrophy and fibrosis in addition to reduction of afterload by natriuretic effect.… read more here.
Keywords: arni; neprilysin inhibitor; group; ctl group ... See more keywords
47 Arni ‘terminates’ traditional heart failure treatment
Sign Up to like & getrecommendations! Published in 2018 at "Heart"
DOI: 10.1136/heartjnl-2018-ics.47
Abstract: Background Heart failure is one of the leading causes of morbidity and mortality in cardiovascular patients. This places significant burden on the health service in Ireland- accounting for 7% of all HSE inpatient bed days.… read more here.
Keywords: arni; heart; class; treatment ... See more keywords